Status:
ACTIVE_NOT_RECRUITING
PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
University of Illinois College of Medicine Rockford
Wake Forest University Health Sciences
Conditions:
Depression
Eligibility:
All Genders
13-19 years
Phase:
NA
Brief Summary
PATH (Promoting AdolescenT Health) 2 Purpose is a two-arm comparative effectiveness research trial to that will evaluate the ability of the interventions, Competent Adulthood Transition with Cognitive...
Detailed Description
The majority of mental, emotional and behavioral (MEB) disorders have an initial onset before age 24, with 20% annual incidence, with major depressive disorder (MDD) being the most common MEB. Health ...
Eligibility Criteria
Inclusion
- Adolescents ages 13 through 19 years, and
- Adolescent must be experiencing an elevated level of depressive symptoms (Patient Health Questionnaire-9 Score = 5-18), and
- Adolescent will be included if they have a past, but not current history of depression.
Exclusion
- Outside age range
- A current diagnosis of Major Depression
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) diagnosis of: schizophrenia, bipolar affective disorder, extreme current drug or alcohol abuse.
- Currently using medication therapy for depression, anxiety, or other internalizing disorders for less than 3 months.
- Currently engaged in individual treatment for a mood disorder
- Currently engaged in a cognitive-behavioral group or therapy
- Any past psychiatric hospitalizations
- Any past self-harm attempt with moderate or greater lethality
- Current suicidal thoughts
- Not willing to comply with the study protocol
- Not willing to participate in the TEAMS groups
- Not willing to be audio recorded during TEAMS groups (only for TEAMS clinics)
- Unable to complete the PHQ-9 screening due to cognitive or intellectual impairment
- Did not complete phone assessment with MINI Kid
- Parent/guardian has a cognitive or intellectual impairment.
- Participant Declined/Changed Mind/Uninterested in participating
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2026
Estimated Enrollment :
636 Patients enrolled
Trial Details
Trial ID
NCT04290754
Start Date
January 1 2020
End Date
October 1 2026
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UI Health
Chicago, Illinois, United States, 60612